LifeSciences BC's Industry Roundtable Featuring Ernst & Young Sells OutA presentation of Beyond Borders, 2008 Global Biotechnology Report by Ernst & YoungOctober 29, 2008  LifeSciences BC was pleased to partner with Ernst & Young to offer this special presentation of Beyond Borders, Ernst & Young Global Biotechnology Report 2008.  Members of our community enjoy breakfast at the Sutton Place Hotel before the presentations Glen Giovanetti, Ernst & Young’s Global Biotechnology Sector Leader was in Vancouver to share his perspective on the current state of the biotechnology industry, insights about emerging trends and the impact of the recent global economy turmoil on the sector. The biotech sector matures, medicine becomes more targeted, globalization accelerates and pharma restructures. Biotech companies are forced to reinvent themselves. In Canada, there is an emerging trend in the distribution of private companies across segments. While one half of the private companies continue to be involved in the development of therapeutics, one third of the companies are now involved in agriculture, aquatics, biomaterials and environment up from one fourth in 2006. Nicole Poirier, a local member of Ernst & Young Global Biotechnology Sector network, Life Sciences Sector and Cleantech Sector leader for British Columbia, was also on hand to speak to participants about the presentation.  Ernst & Young's Nicole Poirier and Glen Giovanetti Bios Glen Giovanetti Glen is Ernst & Young’s Global Biotechnology Sector Leader. Glen has over 23 years of experience with Ernst & Young, including over 15 years serving clients in the biotechnology and medical device industries. He has extensive experience in assisting clients with strategic transactions including public equity and debt offerings, technology licensing and R&D collaborations, and acquisitions. Glen is also experienced in helping companies address the challenges of commercialization including revenue recognition, related reserves and channel inventory. As Global Biotechnology Leader, Glen is responsible for leading of team of professionals in Boston dedicated to understanding the needs of clients, monitoring industry trends and business drivers, and networking and informing professionals serving biotechnology and medical device clients globally. The team is also responsible for producing the Ernst & Young Thought Leadership publications such as Beyond Borders, The Biotechnology Annual Report, now in its 22nd year, and the bio*link and medtech*monitor publications. Glen is a frequent speaker at biotech industry events in the US and around the globe. Glen is a Certified Public Accountant in the states of Massachusetts and California and a member of the American Institute of CPAs, the California Society of CPAs, and the Massachusetts Society of CPAs. Nicole Poirier Nicole is the Ernst & Young Life Sciences Sector and Cleantech Sector leader for British Columbia. Nicole has over 16 years of experience servicing large, mid-sized and small public and private companies. Nicole currently acts as a consultant to clients and other in the firm providing consultative assistance on complex accounting (including IFRS accounting matters), financial reporting and other transactional matters. She also reviews Canadian and U.S. regulatory filings and provides advice on Canadian and U.S. regulatory filling issues. Nicole has been involved with the Life Sciences sector for the last 6 years more recently taking on the role of Life Sciences and Cleantech sectors leader for British Columbia. In her role, Nicole leads a team of professionals that provide services to companies in those sectors. Nicole and her team are part of the Ernst & Young Global Biotechnology Sector and the Cleantech Sector networks. Nicole and her team have direct access to a pool of talented professionals working in those sectors around the world. Nicole has a CA and a CPA (Illinois) designation. |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |